Tuesday, October 26, 2021
Home Tags AstraZeneca

Tag: AstraZeneca

AstraZeneca launches Clinical Trial Data division in India

Drug firm AstraZeneca on Wednesday said it has launched a clinical data and insights division in India for data-related management of its...

DCGI’s nod to AstraZeneca to import, market Selumetinib Capsules

NEW DELHI: Drug firm AstraZeneca Pharma India on Sunday said it has received import and market permission from the Indian drug regulator Drugs Controller General India (DCGI) for...

UK approves Pfizer, AstraZeneca as Booster dose for Covid

LONDON: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on the...

Germany recommends mixing of these vaccines

Berlin: Germany on Friday recommended that people mix AstraZeneca C-19 vaccines with Pfizer or Moderna to enhance immune responses against coronavirus and shorten the interval period between the two shots.

Sun Pharma acquires trademarks of 3 diabetes drug from AstraZeneca

Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca Pharma India's parent...

J&J in discussions with Indian Govt single dose vaccine trial

Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose C-19 vaccine in the country,...

DCGI extends shelf life of Covishield Vaccine

India’s drug regulator (DCGI) has allowed the AstraZeneca C-19 vaccine to be used for up to nine months from its manufacture date,...

DCGI soon to clear way for regular usage authorization of Covaxin

The Drug Control General of India (DCGI) is soon going to remove the ‘trial mode’ tag for Bharat Biotech’s Covaxin C-19 vaccine...

US blocking raw materials will delay our vaccines: Serum complains to...

New Delhi: The head of the world’s biggest vaccine maker and the World Health Organization’s chief scientist said manufacturers of C-19 virus shots...

Chinese hackers target these Indian Vaccine makers

NEW DELHI: A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose C-19...

AstraZeneca gets DCGI nod for Kidney disease drug

New Delhi: AstraZeneca Pharma India on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for Dapagliflozin tablets for the treatment of patients with chronic...

Court rejects Trademark violation lawsuit of ‘Covishield’

A local court has rejected an application seeking an injunction against the use of ‘Covishield’ as a brand name by Serum Institute...

Serum Institute applied to DCGI for local trials of Novavax vaccine

Serum Institute of India (SII) has applied to the DCGI to conduct a small domestic trial of Novavax’s C-19 vaccine, which was...

Suit filed against Serum Institute over use of ‘Covishield’ trademark

A Nanded-based pharma sales company has filed an injunction suit against the Serum Institute of India (SII) at the Commercial Court in...

India will have C-19 vaccine within days: AIIMS

New Delhi: Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep...

India: Oxford vaccine may be approved by next week

India is likely to approve Oxford / AstraZeneca’s C-19 virus vaccine for emergency use by next week after its local manufacturer submitted...

AstraZeneca gets DCGI nod for Asthma drug

NEW DELHI: Drug firm AstraZeneca India on Tuesday said it has received marketing authorisation for an asthma drug from the Drugs Controller General of India (DCGI).

Vaccine can be available in first half of 2021

Oxford-AstraZeneca’s C-19 vaccine can be available in the country as early as the first half of next year, said Gagandeep Singh, Country...

AstraZeneca’s lung disease treatment gets FDA nod

The U.S. Food and Drug Administration approved AstraZeneca's drug to treat patients with a form of lung disease, the British drugmaker said on Friday....

AstraZeneca’s drug for Heart patient approved in India

New Delhi: AstraZenecaPharma India Limited today received the Marketing Authorization for Dapagliflozin (Forxiga), for the treatment of patients with heart failure with reduced ejection fraction (HFrEF).

AstraZeneca strikes deal with Europe’s Inclusive Vaccines

Pharma giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental...

AstraZeneca-Merck’s Lynparza gets US FDA nod for prostate cancer

AstraZeneca-Merck’s Lynparza gets US FDA nod for prostate cancer The US Food and Drug Administration approved AstraZeneca Plc and...

USFDA nod to Lynparza to treat pancreatic cancer

USFDA nod to AstraZeneca and Merck's Lynparza to treat pancreatic cancer. AstraZeneca and Merck & Co's ovarian cancer drug, Lynparza, received...

Latest posts

2 held for illegally selling MTP Kits

A team of the district Health Department conducted a raid and held two persons for allegedly selling MTP kits illegally in the...

Authors

52 POSTS0 COMMENTS
30 POSTS0 COMMENTS
16 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS